|
ZNF655 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.954800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.846600E-01 |
| Normal-vs-Stage2 |
7.704400E-01 |
| Normal-vs-Stage3 |
3.018100E-03 |
| Normal-vs-Stage4 |
4.058600E-01 |
| Stage1-vs-Stage2 |
8.264000E-01 |
| Stage1-vs-Stage3 |
3.479200E-03 |
| Stage1-vs-Stage4 |
3.516800E-01 |
| Stage2-vs-Stage3 |
5.666300E-02 |
| Stage2-vs-Stage4 |
4.173600E-01 |
| Stage3-vs-Stage4 |
1.581010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.215600E-01 |
| Normal-vs-AfricanAmerican |
4.311800E-01 |
| Normal-vs-Asian |
1.531150E-01 |
| Caucasian-vs-AfricanAmerican |
9.106800E-01 |
| Caucasian-vs-Asian |
9.544800E-03 |
| AfricanAmerican-vs-Asian |
1.208410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.419370E-01 |
| Normal-vs-Female |
9.998600E-01 |
| Male-vs-Female |
2.100600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.256200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.355600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.281900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.754400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.782400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.649800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.026400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.680000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.259200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.760600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.541200E-01 |
| Normal-vs-Grade 2 |
7.947200E-01 |
| Normal-vs-Grade 3 |
8.301500E-02 |
| Normal-vs-Grade 4 |
3.266200E-02 |
| Grade 1-vs-Grade 2 |
5.397000E-01 |
| Grade 1-vs-Grade 3 |
1.823600E-01 |
| Grade 1-vs-Grade 4 |
1.014180E-01 |
| Grade 2-vs-Grade 3 |
7.297800E-02 |
| Grade 2-vs-Grade 4 |
3.156200E-02 |
| Grade 3-vs-Grade 4 |
3.395200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.266200E-01 |
| Normal-vs-ccB subtype |
4.813400E-01 |
| ccA subtype-vs-ccB subtype |
4.713800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.495000E-01 |
| Normal-vs-N1 |
4.792600E-01 |
| N0-vs-N1 |
4.345000E-01 |
|
|
